Proteus
Report Name: 2003 Proteus mirabilis
Query Selection Criteria:
Report Start Date: 01/01/2003 (MM/DD/YYYY)
Report End Date: 12/31/2003 (MM/DD/YYYY)
Organism: Proteus mirabilis
Drug: Amikacin;Ampicillin;Cefazolin;Cefepime;Cefotaxime;Ceftazidime;Ce
ftriaxone;Ciprofloxacin;Colistin;Gentamicin;Imipenem;Nitrofurantoi
n;Piperacillin;Piperacillin/tazobactam;Tobramycin;Trimeth/sulfa
Breakpoint: NCCLS
Patient Type: Inpatient;Inpatient - ICU
Patient Age: greater than or equal to 18 AND less than or equal to 120
Institution: T84 University of CA at San Francisco - Parnassus
Street-ALL;T84 Mt. Zion Medical Center - Divisedero Street
Trending: None
Dataset: Institution
Chosen Country: United States
Source: TSN Database
Copyright 2004 Focus Technologies, Inc.
Organism Proteus mirabilis S S I I R R
Drug Total N % N % N %
Amikacin 40 40 100.0 % 0 0.0 % 0 0.0 %
Ampicillin 40 31 77.5 % 0 0.0 % 9 22.5 %
Cefazolin 40 34 85.0 % 2 5.0 % 4 10.0 %
Cefepime 40 40 100.0 % 0 0.0 % 0 0.0 %
Cefotaxime 40 40 100.0 % 0 0.0 % 0 0.0 %
Ceftazidime 40 39 97.5 % 0 0.0 % 1 2.5 %
Ceftriaxone 39 39 100.0 % 0 0.0 % 0 0.0 %
Ciprofloxacin 40 30 75.0 % 2 5.0 % 8 20.0 %
Gentamicin 40 33 82.5 % 2 5.0 % 5 12.5 %
Imipenem 40 40 100.0 % 0 0.0 % 0 0.0 %
Nitrofurantoin 21 0 0.0 % 1 4.8 % 20 95.2 %
Piperacillin 22 20 90.9 % 0 0.0 % 2 9.1 %
Piperacillin/tazobactam 40 40 100.0 % 0 0.0 % 0 0.0 %
Tobramycin 40 35 87.5 % 2 5.0 % 3 7.5 %
Trimeth/sulfa 40 29 72.5 % 0 0.0 % 11 27.5 %
For agents with >25% of strains tested:
Plain=<60% activity